Brief: Summit Healthcare Acquisition Corp- Received Nasdaq Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard On Jan 11
17/01/2023 21:15
Summit Healthcare Acquisition Corp SMIH.O :
* SUMMIT HEALTHCARE ACQUISITION CORP- RECEIVED NASDAQ NOTICE
OF
DELISTING OR FAILURE TO SATISFY A CONTINUED LISTING RULE OR
STANDARD ON JAN 11
Source text for Eikon: ID:
Further company coverage: SMIH.O
Recent news on LakeShore Biopharma Co
See all newsBrief: LakeShore Biopharma Announces Receipt of Delisting Determination Letter from Nasdaq
Brief: LakeShore Biopharma Appoints Advisors to Special Committee Reviewing Takeover Bid
Brief: Lakeshore Biopharma Announces Receipt Of A Preliminary Non-Binding Proposal To Acquire The Company
Brief: Lakeshore Biopharma Expects 2026 Revenue To Be Between RMB550 Million And RMB650 Million
Brief: Lakeshore Biopharma Announces Us$15 Million Private Placement Financing